![Joseph S. Podolski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph S. Podolski
Nessuna posizione attualmente
Storia della carriera di Joseph S. Podolski
Precedenti posizioni note di Joseph S. Podolski
Società | Posizione | Inizio | Fine |
---|---|---|---|
REPROS THERAPEUTICS INC | Direttore/Membro del Consiglio | 01/01/1992 | 01/02/2017 |
Amministratore Delegato | 01/01/1989 | 01/02/2017 | |
Presidente | 01/01/1989 | 01/02/2017 | |
Oncolix, Inc. /Old/
![]() Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | 18/09/2009 | 01/01/2017 |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - | - |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Baxter Pharmaceuticals, Inc.
![]() Baxter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Baxter Pharmaceuticals, Inc. offers a diverse range of generic injectable medicines, including oncology drugs and premixed anti-infectives, analgesics, and critical care medicines. The American company is the only company to provide all three commonly used modern inhaled anesthetics for general anesthesia. Baxter has expanded its pharmaceuticals portfolio through acquisitions, partnerships, and internal development programs to improve access to essential medications and advance pharmacy efficiency and patient care. | Corporate Officer/Principal | - | - |
Formazione di Joseph S. Podolski
Illinois Institute of Technology | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Aziende private | 4 |
---|---|
Repros Therapeutics, Inc.
![]() Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Baxter Pharmaceuticals, Inc.
![]() Baxter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Baxter Pharmaceuticals, Inc. offers a diverse range of generic injectable medicines, including oncology drugs and premixed anti-infectives, analgesics, and critical care medicines. The American company is the only company to provide all three commonly used modern inhaled anesthetics for general anesthesia. Baxter has expanded its pharmaceuticals portfolio through acquisitions, partnerships, and internal development programs to improve access to essential medications and advance pharmacy efficiency and patient care. | Health Technology |
G.D. Searle & Co., Inc.
![]() G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Oncolix, Inc. /Old/
![]() Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- Joseph S. Podolski
- Esperienza